Andrea G Hohmann Selected Research

Andrea G Hohmann Research Topics

Disease

34	Pain (Aches) 11/2021 - 02/2004
29	Hyperalgesia 01/2022 - 02/2004
27	Neuralgia (Stump Neuralgia) 01/2021 - 12/2002
13	Peripheral Nervous System Diseases (PNS Diseases) 01/2022 - 11/2005
12	Hypersensitivity (Allergy) 08/2021 - 01/2008
9	Neoplasms (Cancer) 08/2019 - 12/2009
7	Chronic Pain 10/2021 - 10/2015
7	Inflammation (Inflammations) 07/2019 - 12/2005
4	Ataxia (Dyssynergia) 01/2017 - 10/2008
3	Opioid-Related Disorders (Opiate Addiction) 10/2021 - 01/2018
3	Hypothermia 07/2015 - 06/2011
2	Substance-Related Disorders (Drug Abuse) 01/2022 - 09/2011
2	Peripheral Nerve Injuries 01/2021 - 10/2010
2	Chemotherapy-Related Cognitive Impairment 10/2017 - 01/2017
2	Cognitive Dysfunction 09/2017 - 05/2016
2	Weight Gain 09/2014 - 06/2013
2	Shock 03/2006 - 12/2005
1	Respiratory Insufficiency (Respiratory Failure) 10/2021
1	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 08/2021
1	Post-Traumatic Stress Disorders (Post Traumatic Stress Disorder) 01/2021
1	Tremor (Tremors) 01/2020
1	Osteoarthritis 01/2018

Drug/Important Bio-Agent (IBA)

28	CannabinoidsIBA 10/2021 - 12/2002
24	Paclitaxel (Taxol)FDA LinkGeneric 01/2022 - 11/2008
15	EndocannabinoidsIBA 01/2021 - 03/2006
14	Analgesics (Analgesic Drugs)IBA 10/2021 - 10/2009
11	Opioid Analgesics (Opioids)IBA 10/2021 - 06/2005
9	Morphine (MS Contin)FDA LinkGeneric 01/2021 - 01/2013
9	Cannabinoid Receptors (Cannabinoid Receptor)IBA 01/2019 - 12/2002
6	3- (1,1- dimethyl- heptyl)- 1- hydroxy- 9- methoxy- benzo(c)chromen- 6- oneIBA 01/2022 - 06/2011
6	Pharmaceutical PreparationsIBA 11/2021 - 09/2011
6	Cannabinoid Receptor AgonistsIBA 10/2021 - 02/2004
5	CB2 Cannabinoid ReceptorIBA 01/2022 - 07/2015
5	anandamide (arachidonylethanolamide)IBA 01/2019 - 03/2006
5	Proteins (Proteins, Gene)FDA Link 05/2018 - 05/2009
5	Formaldehyde (Formol)FDA Link 01/2018 - 08/2011
5	Capsaicin (Zostrix)FDA Link 01/2016 - 02/2004
5	Cisplatin (Platino)FDA LinkGeneric 06/2015 - 09/2012
4	CB2 receptor agonist LY2828360IBA 01/2022 - 01/2018
4	EnzymesIBA 10/2021 - 11/2006
4	CannabidiolIBA 01/2021 - 10/2009
4	fatty-acid amide hydrolase (fatty acid amide hydrolase)IBA 01/2021 - 01/2013
4	cyclohexyl carbamic acid 3'-carbamoylbiphenyl-3-yl ester (URB597)IBA 01/2019 - 09/2010
4	URB937IBA 01/2019 - 10/2010
4	Freund's AdjuvantIBA 01/2019 - 10/2015
4	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 05/2018 - 10/2015
4	JZL 184IBA 01/2013 - 09/2010
3	Monoacylglycerol LipasesIBA 01/2021 - 08/2011
3	3- (2- nitro- 1- phenylethyl)- 2- phenyl- 1H- indoleIBA 01/2020 - 11/2018
3	Nitric Oxide Synthase Type I (Neuronal Nitric Oxide Synthase)IBA 05/2018 - 10/2015
3	2- ((1H- benzo(d)(1,2,3)triazol- 5- ylamino)methyl)- 4,6- dichlorophenolIBA 01/2017 - 10/2015
3	iodopravadoline (AM 630)IBA 07/2015 - 09/2010
2	LipidsIBA 10/2021 - 11/2014
2	Vincristine (Oncovin)FDA LinkGeneric 08/2021 - 01/2016
2	Dronabinol (THC)FDA LinkGeneric 01/2021 - 10/2009
2	Naloxone (Narcan)FDA LinkGeneric 11/2020 - 01/2020
2	CB1 Cannabinoid Receptor (CB1 Receptor)IBA 01/2020 - 12/2018
2	Biological ProductsIBA 06/2019 - 03/2013
2	Gabapentin (Neurontin)FDA LinkGeneric 01/2019 - 01/2013
2	Nitric Oxide Synthase (NO Synthase)IBA 05/2018 - 01/2018
2	Nitric Oxide (Nitrogen Monoxide)FDA Link 01/2018 - 10/2015
2	Dizocilpine Maleate (Dizocilpine)IBA 01/2017 - 10/2015
2	RimonabantIBA 07/2015 - 02/2004
2	CreatinineIBA 09/2014 - 06/2013
2	Sodium Bicarbonate (Baking Soda)FDA LinkGeneric 09/2014 - 06/2013
2	KetonesIBA 09/2014 - 06/2013
2	Antineoplastic Agents (Antineoplastics)IBA 09/2014 - 11/2008
2	AM 251 (AM251)IBA 04/2014 - 09/2010
2	nabiximols (Sativex)IBA 01/2014 - 10/2009
1	Oxycodone (Oxycontin)FDA LinkGeneric 01/2022
1	enhanced green fluorescent proteinIBA 01/2022
1	Transcription Factors (Transcription Factor)IBA 01/2022
1	SodiumIBA 11/2021
1	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 10/2021
1	AcidsIBA 10/2021
1	N-acylethanolaminesIBA 10/2021
1	amidaseIBA 10/2021
1	Narcotics (Narcotic Analgesics)IBA 10/2021
1	Fentanyl (Sublimaze)FDA LinkGeneric 10/2021
1	AlkaloidsIBA 08/2021
1	PPAR alphaIBA 01/2021
1	palmidrolIBA 01/2021
1	Anti-Anxiety Agents (Anxiolytics)IBA 01/2021
1	Anti-Bacterial Agents (Antibiotics)IBA 01/2021
1	taxaneIBA 08/2019
1	AmidesIBA 01/2019
1	Fatty Acids (Saturated Fatty Acids)IBA 01/2019
1	diphenyl (biphenyl)IBA 12/2018
1	Therapeutic UsesIBA 12/2018
1	methanandamideIBA 10/2018
1	GTP-Binding Proteins (G-Protein)IBA 01/2018

Therapy/Procedure

24	Drug Therapy (Chemotherapy) 01/2022 - 11/2005
8	Therapeutics 11/2021 - 10/2010
5	Analgesia 01/2021 - 12/2005
4	Pain Management 10/2021 - 07/2019
4	Ligation 01/2019 - 01/2017
2	Self Administration (Administration, Self) 01/2021 - 09/2011
2	Intradermal Injections 01/2016 - 01/2016
2	Immunomodulation 08/2011 - 12/2009
1	Fecal Microbiota Transplantation 01/2021